Cue Biopharma Inc buy Piper Sandler
Start price
03.04.24
/
50%
€1.66
Target price
03.04.25
€7.39
Performance (%)
-63.55%
Price
27.09.24
€0.61
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Cue Biopharma Inc is performing very badly with a performance of -63.55%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cue Biopharma Inc | 16.346% | 16.346% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Piper_Sandler for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat